Compare AU

Compare DRUG vs. IMLC

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are DRUG and IMLC. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

IMLC

Popularity

Low

Low

Pearlers invested

63

1

Median incremental investment

$967.00

$997.50

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,875.72

$2,096.64

Average age group

26 - 35

< 26


Key Summary

DRUG

IMLC

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

IMLC.AX was created on 2023-08-01 by IML. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to outperform the S&P/ASX 300 Accumulation Index (after fees and expenses and before taxes) on a rolling four-year basis.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

IML Conc Aus Shares Fund (Quoted Managed Fund) (100 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.57 %

0.993 %


Key Summary

DRUG

IMLC

Issuer

BetaShares

IML

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.993 %

Price

$8.12

$4.16

Size

$191.120 million

N/A

10Y return

N/A

N/A

Annual distribution/ dividend yield (5Y)

1.90 %

0.52 %

Market

ASX

ASX

First listed date

08/08/2016

31/07/2023

Purchase fee

$6.50

$6.50


Community Stats

DRUG

IMLC

Popularity

Low

Low

Pearlers invested

63

1

Median incremental investment

$967.00

$997.50

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,875.72

$2,096.64

Average age group

26 - 35

< 26


Pros and Cons

DRUG

IMLC

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

DRUG

IMLC

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home